Dudediligence.

SCYNEXIS, Inc

SCYXNASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$19.2Mlast 12 months
Net income
−$10.2Mlast 12 months
Operating cash flow
−$5.9Mlast 12 months
Cash and equivalents
$10.5Mat the last balance sheet
Shares outstanding
9.9M shareson issue
Every year and quarter →